Patent ID: 8349317

Claim:
A method of treating corneal diseases, comprising administering to a patient in need thereof an effective amount of a combination composition comprising as active ingredients: (a) 0.1 to 4 g of L-carnitine and/or one or more alkanoyl L-carnitine, or one of their pharmaceutically acceptable salts, wherein said alkanoyl L-carnitine is selected from the group consisting of acetyl, propionyl, valeryl, isovaleryl, butyryl, and isobutyryl L-carnitine, or one of their pharmaceutically acceptable salts; (b) 0.1 to 1 g of a lipid soluble benzoquinone; and (c) 1 to 10 mg of an omega-3 polyunsaturated fatty acid: and treating said corneal disease in said patient.